Injection of bone marrow cells reduces bleomycin-induced pulmonary fibrosis in mice

M. Yamada, N. Hamada, M. Yoshimi, T. Maeyama, J. Fukumoto, M. Ishizu, K. Kuwano, Y. Nakanishi (Fukuoka, Japan)

Source: Annual Congress 2005 - In vivo - approaches to lung injury
Session: In vivo - approaches to lung injury
Session type: Oral Presentation
Number: 3025
Disease area: Interstitial lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Yamada, N. Hamada, M. Yoshimi, T. Maeyama, J. Fukumoto, M. Ishizu, K. Kuwano, Y. Nakanishi (Fukuoka, Japan). Injection of bone marrow cells reduces bleomycin-induced pulmonary fibrosis in mice. Eur Respir J 2005; 26: Suppl. 49, 3025

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of bone marrow mesenchymal stem cells on bleomycin induced pulmonary fibrosis in rats
Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches
Year: 2006


A study on markers of pulmonary endothelial cells in acute lung injury induced by bone marrow extract injection inrabbits
Source: Eur Respir J 2004; 24: Suppl. 48, 720s
Year: 2004

Bone marrow transplantation reduces susceptibility to pulmonary hypertension in BMPR2 deficient mice
Source: International Congress 2017 – New perspectives from experimental models of pulmonary hypertension
Year: 2017




Effects of bone marrow mononuclear cell therapy in an experimental model of acute lung injury
Source: Annual Congress 2008 - Pathophysiology of respiratory diseases
Year: 2008


Monitoring of lung function and airways inflammation after bone marrow transplantation
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008


Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008


Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009



The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury
Source: Annual Congress 2008 - Pathophysiology of acute lung injury
Year: 2008



Interferon-γ pretreated human MSC show improved efficiency in humanized mice model of pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

Oral presentation: Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009



The effect of pulmonary macrophage transplantation in the pulmonary fibrosis of mice
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


Monitoring of lung function and bronchial inflammation after bone marrow transplantation: preferential recruitment of lymphocytes into the airways
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006


Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis
Source: Eur Respir J 2011; 37: 1217-1225
Year: 2011



Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015


Increased TERT mRNA expression of bone marrow mesenchymal stem cells (BM-MSCs) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010

Effects of bone marrow mononuclear cell therapy in an experimental model of silicosis
Source: Annual Congress 2008 - Respiratory pathophysiology from cell and animal research
Year: 2008


Bleomycin induced lung fibrosis in mice is attenuated by a new somatostatin analog
Source: Annual Congress 2006 - Matrix remodelling at the interface of lung fibrosis and emphysema
Year: 2006


Bone morphogenetic protein 9 protects against neonatal hyperoxia-induced impairment of lung development, inflammation and fibrosis.
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017

LSC 2010 Abstract: Does cigarette smoking influence bone marrow microenvironment? Down-regulation of CXCR4 expression in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): preliminary results
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010